When should a 28-year-old woman with a normal Pap smear repeat screening?

Cervical Cancer Screening for a 28-Year-Old with Normal Pap Smear

For a 28-year-old woman with a normal Pap smear, repeat screening should occur in 1 year if using conventional cytology, or in 2 years if using liquid-based cytology. 1, 2, 3, 4

Age-Specific Screening Recommendations

At age 28, this patient falls into the under-30 age group, which has distinct screening protocols compared to women 30 and older:

For Women Under Age 30:

• Conventional Pap smear: Every 1 year 1, 2, 3, 4
• Liquid-based cytology: Every 2 years 1, 2, 3, 4
• HPV testing is NOT recommended in this age group, either alone or combined with cytology 5, 6

The rationale for more frequent screening in younger women is that while cervical cancer is relatively rare in this age group 7, the screening intervals cannot yet be extended because:

1. HPV infection prevalence is high in women under 30
2. Most infections clear spontaneously
3. HPV testing would result in excessive false positives and unnecessary interventions 8

What Changes at Age 30

Once this patient turns 30, her screening options will expand significantly:

At age 30 and beyond, she can choose:

• Pap test alone every 3 years (after 3 consecutive normal results) 1, 2, 3
• Preferred option: Pap test + HPV co-testing every 3 years 4
• If both Pap and HPV are negative, screening interval can extend to every 3 years 5

Critical Caveats

Do NOT extend screening intervals if the patient has:

• History of cervical cancer or CIN II/III
• HIV infection or immunosuppression
• In-utero DES exposure
• History of abnormal Pap smears 9, 6, 2

These high-risk patients require annual screening regardless of age 6, 9.

Common Pitfall to Avoid

The most common error in practice is over-screening 10, 11. Studies show 55% of American women undergo annual Pap smears even when not indicated 11. While this seems cautious, it leads to:

• Increased false positives
• Unnecessary colposcopies and biopsies
• Higher healthcare costs
• Patient anxiety without mortality benefit 9

The evidence is clear: screening every 1-2 years (compared to every 3 years) improves effectiveness by less than 5% 9, making annual screening in low-risk women inefficient.

Practical Implementation

For this 28-year-old patient with a normal result:

1. Document the cytology method used (conventional vs. liquid-based)
2. Schedule next screening in 1 year (conventional) or 2 years (liquid-based)
3. Counsel that screening frequency will change at age 30
4. Ensure she understands HPV vaccination status does not change screening recommendations 5, 6